Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCheckit Regulatory News (CKT)

Share Price Information for Checkit (CKT)

Share Price is delayed by 15 minutes
Get Live Data
25.00    0.00 (0.00%)
Bid:
24.00
Ask:
26.00
Spread: 2.00 (8.333%)
Market Cap: £27.00m
CKT Live PriceLast checked at - London Stock Exchange

Intraday Checkit Share Chart

Trading Statement

2 Nov 2017 07:00

RNS Number : 3058V
Elektron Technology PLC
02 November 2017
 

Elektron Technology plc

("Elektron", the "Group" or the "Company")

 

Trading Update

 

Elektron Technology plc (AIM: EKT), the global technology group, is pleased to provide an update on trading for the third quarter ended 31 October 2017.

Sales

Group trading was strong in Q3 with sales increasing 34% compared to the same period last year to £8.6m (2017: £6.4m). Year to date sales have increased by 15% to £22.9m (2017: £19.9m).

Bulgin achieved record quarterly sales of £7.8m in Q3, 37% higher than the same period last year (2017: £5.7m) following successful manufacturing scale-up to convert the unprecedented order demand in H1 into sales. The board expects that Bulgin sales will revert to more normal levels through Q4.

 

Sales £m

Unaudited

Unaudited

Q3 2018

Q3 2017

YTD 2018

YTD 2017

Bulgin

7.8

5.7

20.3

17.4

IMC (Queensgate and Elektron Eye Technology)

0.7

0.7

2.3

2.3

Checkit

0.1

0.3

0.2

 

Total

 

8.6

 

6.4

 

22.9

 

19.9

 

Orders

Group order intake remains well ahead of prior year, with all business segments demonstrating growth.

Bulgin and IMC orders are both 20% above prior year levels year to date.

Checkit has continued to build recurring revenue streams and total contracted annual recurring revenue (including forthcoming contracted installations) now stands at £0.7m, compared with £0.3m at the same time last year (+133%).

Cash

Group net cash was approximately £3.0m at 31 October 2017 (31 July 2017: £2.0m; 31 January 2017: £1.0m) following the initial proceeds from the Sheen Instruments disposal of £1.1m in October. The net cash position has also been impacted by investment in working capital of approximately £0.4m as a result of the strong trading performance in this quarter.

John Wilson, Chief Executive Officer of Elektron, said:

"Q3 trading has been strong. The Board now expects full year performance to be ahead of its previous expectations."

Enquiries:

 

Elektron Technology plc 

www.elektron-technology.com

 

+44 (0) 1223 371 000

John Wilson - Chief Executive Officer

 

Andy Weatherstone - Chief Financial Officer & Company Secretary

 

 

 

finnCap (Nominated Adviser & Broker)

+44 (0)20 7220 0500

Ed Frisby / Scott Mathieson - Corporate Finance

 

Abigail Wayne - Corporate Broking

 

 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

Notes to Editors

Elektron conceives designs and markets innovative engineered products and services for businesses that connect, monitor and control. We have a multi skilled team of engineers, software and product line specialists based in Cambridge focused on the opportunities created by global trends in the following areas:

 

- Demand for ubiquitous power and data: Bulgin

- New waves of "aware" business applications: Checkit

- The effect of ageing on sight: Elektron Eye Technology

- Growth in high precision manufacture: Queensgate

 

Cautionary statement

This financial information has been prepared only for the shareholders of Elektron as a whole and its sole purpose and use is to assist shareholders to exercise their governance rights. Elektron and its Directors and employees are not responsible for any other purpose or use or to any other person in relation to this report.

The report contains indications of likely future developments and other forward-looking statements that are subject to risk factors associated with, among other things, the economic and business circumstances occurring from time to time in the countries, sectors and business segments in which the Group operates. Key risks and their mitigation have not changed materially in the period from those disclosed on pages 12 to 14 of the annual financial statements for the year ended 31 January 2017.

These and other factors could adversely affect the Group's results, strategy and prospects. Forward-looking statements involve risks, uncertainties and assumptions. They relate to events and/or depend on circumstances in the future which could cause actual results and outcomes to differ materially from those currently anticipated. No obligation is assumed to update any forward-looking statements, whether as a result of new information, future events or otherwise.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBUBDBCSGBGRB
Date   Source Headline
1st Feb 20137:00 amRNSTrading update
28th Jan 20137:00 amRNSHolding(s) in Company
10th Jan 20134:51 pmRNSHolding(s) in Company
2nd Jan 20132:54 pmRNSCompletion of disposal
3rd Dec 20127:00 amRNSProduct Launch
28th Nov 20127:00 amRNSDirector/PDMR Shareholding
27th Nov 20127:00 amRNSDisposal
1st Oct 20123:16 pmRNSDirector/PDMR Shareholding
13th Sep 20121:26 pmRNSDirector/PDMR Shareholding
13th Sep 20127:00 amRNSHalf year results
3rd Sep 20127:00 amRNSProduct Launch
31st Aug 20129:10 amRNSNotice of Results
23rd Aug 20124:37 pmRNSHolding in Company
21st Aug 20124:09 pmRNSDirector/PDMR Shareholding
20th Aug 201211:35 amRNSCorrection: Issue of scrip dividend shares
13th Aug 20128:04 amRNSIssue of Equity
31st Jul 20127:00 amRNSLaunch of new range of waterproof connectors
25th Jul 20124:16 pmRNSHolding(s) in Company
17th Jul 20121:15 pmRNSHolding(s) in Company
10th Jul 20121:50 pmRNSHolding(s) in Company
6th Jul 201211:47 amRNSHolding(s) in Company
3rd Jul 20127:00 amRNSBoard Changes
28th Jun 20125:36 pmRNSResolutions Passed
28th Jun 201210:19 amRNSDirector Dealing
28th Jun 20127:00 amRNSAGM Statement
7th Jun 201210:33 amRNSHolding(s) in Company
17th May 20127:00 amRNSAnnual Report and Notice of AGM
12th Apr 20127:00 amRNSFull year results
30th Mar 201211:04 amRNSNotice of Results
21st Feb 201210:27 amRNSHolding(s) in Company
1st Feb 20127:00 amRNSTrading update
18th Jan 20127:00 amRNSDirector/PDMR Shareholding
29th Dec 201112:57 pmRNSDirector/PDMR Shareholding
20th Dec 20117:00 amRNSDirector/PDMR Shareholding
9th Dec 20118:13 amRNSDirector/PDMR Shareholding
5th Dec 20117:00 amRNSDirector/PDMR Shareholding
30th Nov 20117:00 amRNSIssue of Equity
23rd Nov 201112:13 pmRNSHolding(s) in Company
22nd Nov 20111:14 pmRNSDirector/PDMR Shareholding
17th Nov 20117:00 amRNSTrading update
16th Nov 20111:24 pmRNSHolding(s) in Company
9th Nov 20117:00 amRNSHolding(s) in Company
4th Oct 20114:28 pmRNSDoc re. interim report and scrip dividend circular
20th Sep 20117:00 amRNSHolding(s) in Company
15th Sep 20117:00 amRNSHalf Yearly Report
24th Aug 201111:58 amRNSHolding(s) in Company
23rd Aug 20114:53 pmRNSDirector/PDMR Shareholding
23rd Aug 20114:46 pmRNSHolding(s) in Company
12th Aug 20117:00 amRNSIssue of Scrip Dividend Shares
29th Jul 20113:01 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.